DAWN vs PNC · rev $131.2M vs P/E 14, rev $6.88B
Day One Biopharmaceuticals Inc (DAWN) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
DAWN currently screens at market cap $656.8M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the DAWN and PNC stock pages for the full models.
Not investment advice.